tiprankstipranks
Trending News
More News >
Standard BioTools (LAB)
NASDAQ:LAB
US Market

Standard BioTools (LAB) Income Statement

Compare
465 Followers

Standard BioTools Income Statement

Last quarter (Q3 2025), Standard BioTools's total revenue was $19.55M, a decrease of -56.52% from the same quarter last year. In Q3, Standard BioTools's net income was $-34.69M. See Standard BioTools’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 174.43M$ 106.34M$ 97.95M$ 130.58M$ 138.14M
Gross Profit
$ 84.26M$ 50.45M$ 37.05M$ 69.37M$ 83.33M
Operating Expenses
$ 259.50M$ 127.05M$ 153.26M$ 136.83M$ 134.36M
Depreciation and Amortization
$ 16.86M$ 15.18M$ 15.03M$ 15.57M$ 15.92M
EBITDA
$ -118.14M$ -54.46M$ -173.57M$ -44.27M$ -34.60M
Operating Income
$ -175.24M$ -76.60M$ -116.20M$ -67.46M$ -51.04M
Other Income/Expenses
$ 36.92M$ 2.40M$ -76.72M$ 3.80M$ -3.06M
Pretax Income
$ -138.31M$ -74.20M$ -192.93M$ -63.66M$ -54.10M
Net Income
$ -138.88M$ -74.66M$ -190.10M$ -59.24M$ -53.02M
Per Share Metrics
Basic EPS
$ -0.52$ -0.94$ -2.43$ -0.78$ -0.74
Diluted EPS
$ -0.52$ -0.94$ -2.43$ -0.78$ -0.74
Weighted Average Shares Outstanding
352.67M 79.16M 78.31M 75.79M 72.04M
Weighted Average Shares Outstanding (Diluted)
352.67M 79.16M 78.31M 75.79M 72.04M
Currency in USD

Standard BioTools Earnings and Revenue History